Matches in SemOpenAlex for { <https://semopenalex.org/work/W2564649049> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2564649049 endingPage "185" @default.
- W2564649049 startingPage "182" @default.
- W2564649049 abstract "Amac: Anti-CCP antikorlari romatoid artritin (RA) tani koydurucu belirteclerinden bir tanesi olmakla birlikte sis- temik lupus eritematozus (SLE), primer Sjogren sendromu (pSS) gibi diger hastaliklarda da saptanabilmektedir. Yetiskinlerde tiroid otoimmunitesi (TO) ve anti-CCP pozitifligiyle ilgili gunumuze kadar herhangi bir veri yayin- lanmamistir. Biz bu calismada yetiskin TO olan hastalarda anti-CCP pozitifligi yayginligini saptamayi amacladik. Yontem ve Gerecler: Ocak 2010-Ekim 2014 tarihleri arasinda anti-CCP, RF ve anti-tiroid peroksidoz (anti-TPO) ve/veya TSH reseptor antikoru (TRAb) istenen 1282 hastanin kayitlari tibbi kayit sisteminden retrospektif olarak incelendi. TO, tanisi tiroid otoantikorlarinin normal degerlerinin ust sinirinin uzerinde saptanmasi ile kondu. RF ve anti-CCP pozitifligi degerler normal araligin uzerinde oldugu zaman dusunuldu. Bulgular: TO olan grupta,TPO-Ab, TRAb, CCP ve RF pozitifligi sirasiyla 332 (%99), 7 (%2), 44 (%13), ve 78 (%23) olarak saptandi. TO olmayan grupta 70 kiside Anti-CCP pozitifligi (%7.4) ve 378 kiside RF pozitifligi (%20) saptandi. Anti-CCP pozitiflik orani TO olan grupta TO olmayan gruba gore anlamli olarak daha yuksek saptandi (%13 vs.%7.4, p<0.001). Ancak RF pozitifligi yonunden gruplar arasinda anlamli olarak fark yoktu. Sonuc: Bizim calismamiz TO olan hastalarda anti-CCP prevalansinin arttigini gostermistir. Bu da bize Anti-CCP antikorlarinin RA’ya ek olarak TO olanlarda da gorulebilecegini dusundurur." @default.
- W2564649049 created "2017-01-06" @default.
- W2564649049 creator A5000183009 @default.
- W2564649049 creator A5014114164 @default.
- W2564649049 creator A5055652128 @default.
- W2564649049 creator A5089475753 @default.
- W2564649049 date "2016-12-28" @default.
- W2564649049 modified "2023-10-16" @default.
- W2564649049 title "The prevalence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in patients with thyroid autoimmunity" @default.
- W2564649049 cites W1968304195 @default.
- W2564649049 cites W1987821434 @default.
- W2564649049 cites W2013573826 @default.
- W2564649049 cites W2043348791 @default.
- W2564649049 cites W2048542760 @default.
- W2564649049 cites W2054024602 @default.
- W2564649049 cites W2056318103 @default.
- W2564649049 cites W2059133002 @default.
- W2564649049 cites W2076036152 @default.
- W2564649049 cites W2086892531 @default.
- W2564649049 cites W2108595441 @default.
- W2564649049 cites W2128952811 @default.
- W2564649049 doi "https://doi.org/10.21601/ortadogutipdergisi.292160" @default.
- W2564649049 hasPublicationYear "2016" @default.
- W2564649049 type Work @default.
- W2564649049 sameAs 2564649049 @default.
- W2564649049 citedByCount "0" @default.
- W2564649049 crossrefType "journal-article" @default.
- W2564649049 hasAuthorship W2564649049A5000183009 @default.
- W2564649049 hasAuthorship W2564649049A5014114164 @default.
- W2564649049 hasAuthorship W2564649049A5055652128 @default.
- W2564649049 hasAuthorship W2564649049A5089475753 @default.
- W2564649049 hasBestOaLocation W25646490492 @default.
- W2564649049 hasConcept C159654299 @default.
- W2564649049 hasConcept C163764329 @default.
- W2564649049 hasConcept C203014093 @default.
- W2564649049 hasConcept C2779281246 @default.
- W2564649049 hasConcept C2780130043 @default.
- W2564649049 hasConcept C50181227 @default.
- W2564649049 hasConcept C55493867 @default.
- W2564649049 hasConcept C71924100 @default.
- W2564649049 hasConcept C86803240 @default.
- W2564649049 hasConceptScore W2564649049C159654299 @default.
- W2564649049 hasConceptScore W2564649049C163764329 @default.
- W2564649049 hasConceptScore W2564649049C203014093 @default.
- W2564649049 hasConceptScore W2564649049C2779281246 @default.
- W2564649049 hasConceptScore W2564649049C2780130043 @default.
- W2564649049 hasConceptScore W2564649049C50181227 @default.
- W2564649049 hasConceptScore W2564649049C55493867 @default.
- W2564649049 hasConceptScore W2564649049C71924100 @default.
- W2564649049 hasConceptScore W2564649049C86803240 @default.
- W2564649049 hasIssue "4" @default.
- W2564649049 hasLocation W25646490491 @default.
- W2564649049 hasLocation W25646490492 @default.
- W2564649049 hasOpenAccess W2564649049 @default.
- W2564649049 hasPrimaryLocation W25646490491 @default.
- W2564649049 hasRelatedWork W1501408339 @default.
- W2564649049 hasRelatedWork W1996464156 @default.
- W2564649049 hasRelatedWork W2017482091 @default.
- W2564649049 hasRelatedWork W2058737939 @default.
- W2564649049 hasRelatedWork W2101875571 @default.
- W2564649049 hasRelatedWork W2146466204 @default.
- W2564649049 hasRelatedWork W2469794603 @default.
- W2564649049 hasRelatedWork W2907025905 @default.
- W2564649049 hasRelatedWork W4221024504 @default.
- W2564649049 hasRelatedWork W1564372652 @default.
- W2564649049 hasVolume "8" @default.
- W2564649049 isParatext "false" @default.
- W2564649049 isRetracted "false" @default.
- W2564649049 magId "2564649049" @default.
- W2564649049 workType "article" @default.